About Noradrenaline Bitartrate EQ. to Noradrenaline 2mg
Noradrenaline Bitartrate EQ. to Noradrenaline 2mg is a sterile injectable solution of norepinephrine bitartrate, where 4 mg of the bitartrate salt provides the equivalent of 2 mg norepinephrine base (noradrenaline base).
It acts as a potent vasopressor and inotrope, primarily used to treat severe acute hypotension or shock (e.g., septic, cardiogenic, neurogenic), by stimulating alpha-adrenergic receptors to increase blood pressure and peripheral vascular resistance.
Typically supplied in 2 mL ampoules (2 mg/mL base equivalent), it's administered via IV infusion after dilution, with careful titration starting at 0.05-0.1 g/kg/min base, and protected from light.
Rapid Support in Critical HypotensionArkoline-2 delivers swift and effective support for patients with dangerously low blood pressure following fluid replacement, particularly in cases of septic, distributive, cardiogenic, and neurogenic shock. The alpha-1 agonist action enhances vascular tone, achieving a significant and targeted rise in mean arterial pressure necessary for organ perfusion and patient stabilization.
Sterile and Convenient Injectable FormulationEach ampoule contains a liquid concentrate of noradrenaline bitartrate, precisely formulated to provide safe and accurate dosing. The 2ml ampoules allow for straightforward dilution and continuous IV infusion. Administered via central line, this product ensures consistency and reliability for critical care teams.
Safe Handling and Storage GuidelinesTo maintain efficacy and sterility, Arkoline-2 must be stored in a cool, dry environment. The 24-month shelf life permits flexibility in stock management for hospitals and clinics. Proper handling by trained healthcare professionals ensures best therapeutic outcomes and patient safety.
FAQ's of Noradrenaline Bitartrate EQ. to Noradrenaline 2mg:
Q: How is Arkoline-2 (Noradrenaline Bitartrate Injection) administered to patients?
A: Arkoline-2 is administered by healthcare professionals via continuous intravenous infusion, typically through a central venous line, after proper dilution in a suitable infusion fluid. This method ensures precise control over blood pressure management in critically ill patients.
Q: What medical conditions can Arkoline-2 be used to treat?
A: This product is used to treat hypotensive states-most commonly after adequate fluid resuscitation-such as septic/distributive shock, cardiogenic shock, and neurogenic hypotension, where vasoconstriction is necessary to raise arterial pressure.
Q: When should Arkoline-2 be considered for use in critical care?
A: Arkoline-2 is indicated when patients remain hypotensive (systolic/diastolic pressure does not meet clinical targets) even after receiving adequate fluid resuscitation, particularly in cases of shock due to sepsis or other distributive, cardiogenic, or neurogenic causes.
Q: What are the steps involved in preparing Arkoline-2 for infusion?
A: A healthcare professional will dilute the appropriate ampoule content in a suitable intravenous fluid according to the hospital protocol, then administer it as a continuous infusion through a central line, carefully monitoring the patient's blood pressure and response.
Q: Where should Arkoline-2 ampoules be stored for optimal safety and efficacy?
A: Ampoules should be kept in a cool, dry place, away from direct light and heat. Proper storage prevents degradation of the active ingredient and ensures the medication remains effective throughout its 24-month shelf life.
Q: What are the main benefits of using Arkoline-2 in shock management?
A: The principal benefit is rapid and controlled elevation of mean arterial pressure via potent vasoconstriction, supporting organ perfusion during life-threatening hypotensive crises and improving outcomes in carefully monitored critical care settings.